48,453
edits
Difference between revisions of "Mammary myofibroblastoma"
Jump to navigation
Jump to search
Mammary myofibroblastoma (view source)
Revision as of 04:15, 16 February 2014
, 04:15, 16 February 2014→IHC
(→IHC) |
|||
| Line 72: | Line 72: | ||
*CD34 +ve.<ref name=pmid11474286/> | *CD34 +ve.<ref name=pmid11474286/> | ||
*Desmin +ve.<ref name=pmid11474286/> | *Desmin +ve.<ref name=pmid11474286/> | ||
*Actin +ve. | *Actin +ve. | ||
*Vimentin +ve. | *Vimentin +ve. | ||
Others: | |||
* | *S-100 -ve.<ref name=pmid24298520/> | ||
*Beta-catenin -ve. | *Beta-catenin -ve.{{fact}} | ||
*H-caldesmon -ve.<ref>{{Cite journal | last1 = Mnif | first1 = H. | last2 = Charfi | first2 = S. | last3 = Abid | first3 = N. | last4 = Sallemi-Boudawara | first4 = T. | title = Mammary myofibroblastoma with leiomyomatous differentiation: case report and literature review. | journal = Pathologica | volume = 105 | issue = 4 | pages = 142-5 | month = Aug | year = 2013 | doi = | PMID = 24466766 }}</ref>{{fact}} | |||
*CK7 -ve.<ref name=pmid24298520>{{Cite journal | last1 = Shivali | first1 = B. | last2 = S | first2 = K. | last3 = Chandramouleeswari | first3 = K. | last4 = Anita | first4 = S. | title = Myofibroblastoma breast with unusual morphological features. Cytohistopathogical diagnostic pitfalls and role of immunohistochemistry-review of literature. | journal = J Clin Diagn Res | volume = 7 | issue = 10 | pages = 2323-5 | month = Oct | year = 2013 | doi = 10.7860/JCDR/2013/5281.3515 | PMID = 24298520 }}</ref> | |||
==See also== | ==See also== | ||